Tag «Glenmark Life Sciences IPO Grey market premium»

Glenmark Life Sciences Ltd

About the Company: Glenmark Life Sciences Ltd is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas, including cardiovascular disease (“CVS”), central nervous system disease (“CNS”), pain management and diabetes Company also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives and other therapeutic areas. Company’s API …